Evaxion Biotech Ownership | Who Owns Evaxion Biotech?
Evaxion Biotech Ownership Summary
Evaxion Biotech is owned by 3.94% institutional investors, 17.47% insiders, and 78.59% retail investors. Ikarian capital is the largest institutional shareholder, holding 0.90% of EVAX shares. PSM Macro Strategy is the top mutual fund, with 0.78% of its assets in Evaxion Biotech shares.
EVAX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evaxion Biotech | 3.94% | 17.47% | 78.59% |
| Sector | Healthcare Stocks | 35.59% | 11.88% | 52.53% |
| Industry | Biotech Stocks | 35.80% | 11.85% | 52.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ikarian capital | 74.70K | 0.90% | $277.88K |
| Rathbones group | 45.72K | 0.55% | $170.09K |
| Renaissance | 39.23K | 0.47% | $145.92K |
| Annis gardner whiting capital advisors | 30.00K | 0.36% | $111.60K |
| Xtx topco | 22.05K | 0.26% | $82.04K |
| Rhumbline advisers | 21.66K | 0.26% | $80.56K |
| Stonepine capital management | 19.71K | 0.24% | $73.33K |
| Boothbay fund management | 18.43K | 0.22% | $68.55K |
| Citadel advisors | 17.77K | 0.21% | $66.12K |
| Wesbanco bank | 10.00K | 0.12% | $37.20K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Stonepine capital management | 19.71K | 0.03% | $73.33K |
| Ikarian capital | 74.70K | 0.02% | $277.88K |
| Annis gardner whiting capital advisors | 30.00K | 0.02% | $111.60K |
| Xtx topco | 22.05K | 0.00% | $82.04K |
| Wesbanco bank | 10.00K | 0.00% | $37.20K |
| Boothbay fund management | 18.43K | 0.00% | $68.55K |
| Gamma investing | 5.20K | 0.00% | $19.34K |
| Rathbones group | 45.72K | 0.00% | $170.09K |
| Eversource wealth advisors | 720.00 | 0.00% | $11.69K |
| Renaissance | 39.23K | 0.00% | $145.92K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rathbones group | 45.72K | 0.00% | 45.72K |
| Renaissance | 39.23K | 0.00% | 39.23K |
| Annis gardner whiting capital advisors | 30.00K | 0.02% | 30.00K |
| Xtx topco | 22.05K | 0.00% | 22.05K |
| Citadel advisors | 17.77K | - | 17.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -33.10K |
| Royal bank of canada | - | - | -3.90K |
| Ubs group | - | - | -3.22K |
| Eversource wealth advisors | 720.00 | 0.00% | -1.99K |
| Stonepine capital management | 19.71K | 0.03% | -287.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Rathbones group | 45.72K | 0.00% | 45.72K | $170.09K |
| Renaissance | 39.23K | 0.00% | 39.23K | $145.92K |
| Annis gardner whiting capital advisors | 30.00K | 0.02% | 30.00K | $111.60K |
| Xtx topco | 22.05K | 0.00% | 22.05K | $82.04K |
| Citadel advisors | 17.77K | - | 17.77K | $66.12K |
Sold Out
| Holder | Change |
|---|---|
| Ubs group | -3.22K |
| Royal bank of canada | -3.90K |
| Point72 asset management | -33.10K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 15 | 15.38% | 328,604 | 53.38% | 3 | 35.25% | 7 | -30.00% | 3 | - |
| Dec 31, 2025 | 13 | 116.67% | 214,235 | 83.83% | 3 | 101.08% | 10 | 900.00% | 3 | 50.00% |
| Sep 30, 2025 | 6 | -25.00% | 116,537 | -2.69% | 1 | 52.07% | 1 | - | 2 | -33.33% |
| Jun 30, 2025 | 8 | -11.11% | 119,755 | -12.63% | 1 | 40.85% | 1 | -87.50% | 3 | 200.00% |
| Mar 31, 2025 | 9 | - | 137,061 | -83.01% | 2 | 33.76% | 8 | 100.00% | 1 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| PSM Macro Strategy | 65.00K | 0.78% | 23.00K |
| PSM Value Strategy UI | 40.00K | 0.48% | - |
| NewDeal Invest, kl n | 15.74K | 0.27% | - |
| Fidelity Nasdaq Composite Index | 621.00 | 0.01% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q1 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q1 | - | - |
EVAX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools